Skip Navigation

A Phase IB Study of Nivolumab in Patients with Autoimmune Disorders and Advanced Malignancies AIM-NIVO

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03816345

Study #:
STUDY00146187

Start Date:
Mar 04, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03816345

View Complete Trial Details & Eligibility at ClinicalTrials.gov